FIGQY phosphorylation defines discrete populations of L1 cell adhesion molecules at sites of cell-cell contact and in migrating neurons by unknown
INTRODUCTION
Cell adhesion and signal transduction are intertwined in cell
functioning. Involvement of cell adhesion molecules (CAMs)
in signaling cascades has become accepted for all the major
families of CAMs, including integrins, cadherins and Ig CAMs
(Walsh and Doherty, 1997; Jones et al., 1999; Behrens, 1999).
Support for the participation of cell adhesion molecules in
intracellular signaling is based largely on experiments
performed in vitro and in cell culture. However, functionally
important signaling events in metazoans occur in the
complex environment of multicellular organisms. Detailed
understanding of pathways that integrate cell adhesion and
signaling will ultimately require knowledge of the specific
amino acid residue(s) subject to phosphorylation, as well as the
precise cellular localization of the relevant regulatory signals,
protein kinases, protein phosphatases and adapter proteins. A
necessary first step in elucidating a physiologically relevant
pathway would be to determine, at high resolution in tissues of
an intact organism, the cellular localization of cell adhesion
molecules phosphorylated at specific amino acid residues.
Surprisingly, little information at this physiological level is
currently available for the major classes of cell adhesion
molecules.
This study takes that necessary first step by addressing the
physiological localization of the L1 family of cell adhesion
molecules phosphorylated at a highly conserved tyrosine
residue located in the cytoplasmic domain within the ankyrin-
binding site (Garver et al., 1997). To our knowledge, this study
and that of Chen et al. (Chen et al., 2001) are the first to address
the physiological occurrence of a specific, functionally
important phosphorylation event in a major family of cell
adhesion molecules. The L1 family comprises L1, neurofascin,
NrCAM, NgCAM and CHL-1 in vertebrates, and neuroglian
and LAD-1 in Drosophila and Caenorhabditis elegans,
respectively (Bieber et al., 1989; Hortsch, 1996; Chen et al.,
2001). Subsequently, the term L1 CAMs will be used to
describe vertebrate family members and L1-type will be used
to include both vertebrate and invertebrate L1 family members. 
L1-type adhesion molecules are comprised of variable
extracellular domains made up of immunoglobulin and
fibronectin type III repeats, which can contribute to both
homophilic and heterophilic binding, and a relatively
conserved cytoplasmic domain that associates with ankyrin
(Davis et al., 1993; Hortsch, 2000). The clinical importance of
L1 CAMs is evident from mutations in L1 itself which result
in mental retardation and hydrocephalus (Fransen et al., 1997;
Kamiguchi et al., 1998; Kenwrick et al., 2000). The L1-type
adhesion molecules have been implicated in processes
important for nervous system development including axon
guidance (Stoeckli and Landmesser, 1995; Cohen et al., 1998),
neuronal process extension (Seilheimer, and Schachner, 1988;
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Phosphorylation of neurofascin, a member of the L1 family
of cell adhesion molecules (L1 CAMs), at the conserved
FIGQY-tyrosine abolishes the ankyrin-neurofascin
interaction. This study provides the first evidence, in
Drosophila melanogaster and vertebrates, for the
physiological occurrence of FIGQY phosphorylation in L1
family members. FIGQY tyrosine phosphorylation is
localized at specialized cell junctions, including paranodes
of sciatic nerve, neuromuscular junctions of adult rats and
Drosophilaembryos, epidermal muscle attachment sites of
Drosophila, and adherens junctions of developing epithelial
cells of rat and Drosophila. In addition, FIGQY-
phosphorylated L1 CAMs are abundantly expressed in
regions of neuronal migration and axon extension,
including the embryonic cortex, the neonatal cerebellum
and the rostral migratory stream, a region of continued
neurogenesis and migration throughout adulthood in the
rat. Based on our results, physiological FIGQY-tyrosine
phosphorylation of the L1 family likely regulates adhesion
molecule-ankyrin interactions establishing ankyrin-free
and ankyrin-containing microdomains and participates in
an ankyrin-independent intracellular signaling pathway at
specialized sites of intercellular contact in epithelial and
nervous tissue. 
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Demyanenko et al., 1999), cell migration (Lindner et al., 1983)
and axon fasciculation (Lemmon and McLoon, 1986; Rathjen
et al., 1987; Honig et al., 1998). L1 CAMs are also likely
involved in the formation and/or functioning of nodes of
Ranvier because a 186 kDa neurofascin isoform and NrCAM
are enriched in the axon nodal segment of adult and developing
myelinated axons (Davis et al., 1996; Lambert et al., 1997; Tait
et al., 2000). Moreover, a 155 kDa neurofascin isoform is a
component of the paranodal loops of Schwann cells and may
contribute to axo-glial contacts (Tait et al., 2000). 
In addition to their prominent localization in the nervous
system, NrCAM and L1 have been identified in multiple non-
neuronal tissues including pancreas, placenta, adrenal glands
and cells of the immune system (Kadmon et al., 1998; Wang
et al., 1998). L1 is also expressed in a variety of epithelial
tissues including the epidermis, lung, small intestine and colon
(Nolte et al., 1999). Neuroglian, the DrosophilaL1 ortholog,
is expressed in hindgut, muscle, trachea and salivary glands in
addition to the nervous system (Hortsch et al., 1990). LAD-1,
the C. elegansL1 CAM, is expressed ubiquitously at sites of
cell-cell contact beginning at the two cell stage (Chen et al.,
2001). Although these findings suggest the fundamental
importance of L1-type adhesion molecules outside the
nervous system, little work has emphasized their non-neuronal
roles. 
L1-type adhesion molecules have been implicated in a
variety of signal transduction pathways. Potential protein
kinases interacting directly or indirectly with this family
include Src (Ignelzi et al., 1994), the Eph kinase Cek5 (Zisch
et al., 1997), the fibroblast growth factor receptor (FGFR)
(Saffell et al., 1997; Garcia-Alonso et al., 2000; Chen et al.,
2001), and the mitogen-activated protein kinase (MAPK)
(Schmid et al., 2000; Schaefer et al., 1999). Nerve growth
factor and fibroblast growth factor both promote
phosphorylation of neurofascin in cultured neuroblastoma cells
at a site identified as the conserved FIGQY tyrosine residue in
the ankyrin-binding motif (Garver et al., 1997, Tuvia et al.,
1997). Phosphorylation of the FIGQY-tyrosine abolishes
ankyrin binding and neurofascin-mediated cell segregation
(Garver et al., 1997; Tuvia et al., 1997). The FIGQY/H
mutation in human L1 results in clinical disease, suggesting a
critical role of the FIGQY-tyrosine in either ankyrin-binding
and/or signaling (Fransen et al., 1998). Additionally, FIGQY
tyrosine phosphorylation in C. eleganshas been hypothesized
to be involved in maintenance of tissue integrity during
mechanical stress, based on its localization at intercellular
junctions in epithelial tissues that experience mechanical strain
(Chen et al., 2001). 
This study demonstrates that phosphorylation of the FIGQY
tyrosine of L1-type adhesion molecules occurs in neuronal and
non-neuronal tissues of the rat and Drosophila using an
antibody specific for the phospho-FIGQY tyrosine. FIGQY-
phosphorylated L1-type adhesion molecules are localized by
immunofluorescence at sites of cell-cell contact in nervous
system and in epithelial tissues. These results, and those of
Chen et al. (Chen et al., 2001) describing the localization of
FIGQY-phosphorylated LAD-1 in C. elegans, suggest the
presence of a novel signaling pathway that is important for
regulating L1-type adhesion molecule function in multiple
developmental stages and anatomical locations, and that is
conserved among family members. 
MATERIALS AND METHODS
SDS-PAGE and Immunoblotting
SDS-PAGE and immunoblot analysis using 125I-labeled protein A and
autoradiography were performed as described (Garver et al., 1997;
Lambert et al., 1997). Some immunoblots (immunoprecipitates
and ovalbumin-coupled peptides) were developed using enhanced
chemiluminesence (ECL) (Amersham). Brain tissue for
immunoblotting was homogenized in four volumes of ice-cold
homogenzation buffer (10 mM phosphate buffer (pH 7.3) containing
0.32 M sucrose, 10 mM sodium fluoride, 1.0 mM EDTA, 1.0 mM
AEBSF, 10 µg/ml leupeptin, and 1.0 mM vanadate). Homogenates
were immediately added to 5× PAGE buffer (50 mM Tris, pH 8.0,
5.0% SDS, 25% sucrose, 5.0 mM EDTA, 200 mM DTT, Bromophenol
Blue), and boiled for 5 minutes. For immunoprecipitation of L1
CAMs, embryonic and neonatal brains were homogenized in ice-cold
modified RIPA buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 0.5%
sodium deoxycholate, 0.5% NP-40, 1.0 mM benzamidine, 1.0 mM
EDTA, 20 mM NaF, 1.0 mM Na3VO4, 1.0 mM PMSF, 1.0 mM
AEBSF and 10 µg/ml leupeptin). Homogenates were centrifuged to
pellet particulate material and the supernatants were incubated
overnight at 4°C with the indicated antibody. Immune complexes were
precipitated with protein A sepharose beads. 
Cell culture and transfection
B104 rat neuroblastoma cells plated at 1-3× 05 cells per 35 mm plate
were cultured in Dulbecco’s Modified Eagle’s Medium (Gibco)
containing 1.0% fetal bovine serum (HyClone), 2.0 mM glutamine
(Gibco), and 1.0% Pen-Strep (Gibco). Cells were transfected with
either HA-tagged wild-type neurofascin or FIGQY to F mutant
neurofascin using Lipofectamine (Gibco). Thirty-six hours after
transfection, cells were switched to serum-free medium and incubated
overnight before being treated with 50 ng/ml basic FGF for 45
minutes. Cells were harvested in 50 mM Tris Cl (pH 7.5), 0.5%
deoxycholate, 1.0% NP40, 1.0% TritonX-100, 1.0 mM EDTA, PMSF
(200 µg/ml), AEBSF (2 mM), leupeptin and pepstatin (10 µg/ml),
dephostatin (50 µM), sodium vanadate (1.0 mM) and sodium fluoride
(1.0 mM). FIGQY to F mutant neurofascin was made using the
QuickChange site-directed mutagenesis kit (Stratagene) as described
(Zhang et al., 1998). 
Immunocytochemistry
Perfusion of adult rats with 2.0% paraformaldehyde and
immunocytochemistry with frozen sections of rat brain, sciatic nerve
nd whole embryos were performed as described (Kordeli et al.,
1990; Davis et al., 1996). Neuromuscular junction preparation and
immunofluorescence were performed as described (Kramarcy and
Sealock, 2000). For phosphatase treatment of embryonic (E17) brain
sections, sections were incubated at 30°C for 3 hours with 3.3 units/µl
of the protein tyrosine phosphatase YOP (New England Biolabs)
(approximately 60 U of phosphatase per tissue section) in the buffer
supplied by the manufacturer. Sections were then processed for
immunofluorescence. 
Antibodies used include a polyclonal antibody against the
cytoplasmic domain of neurofascin (Davis et al., 1993), a polyclonal
antibody against NrCAM (Davis et al., 1996), a polyclonal antibody
against L1 (a gift from Dr C. Lagenaur) (Chung et al., 1991), a
monoclonal antibody (1B7) that recognizes both isoforms of
neuroglian (a gift from Dr M. Hortsch) (Bieber et al., 1989), a
monoclonal antibody against FasII (a gift from Dr C. Goodman)
(Seeger et al., 1993; Van Vactor et al., 1993), a monoclonal antibody
against PS alpha 2 (a gift from Dr J. Bloor) (Bogeart et al., 1987), a
goat polyclonal antibody against horseradish peroxidase (ICN) (Desai
et al., 1994), and a monoclonal antibody against a neuron-specific β-
tubulin (TUJ1) (BabCO). Secondary antibodies used were goat anti-
rabbit rhodamine and goat anti-mouse FITC, donkey anti-mouse FITC,
donkey anti-rabbit TRITC and donkey anti-goat Cy5 (Jackson Labs).
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Drosophila lines 
All Drosophila stocks were raised at 25°C on standard
cornmeal/molasses/agar media. The following lines were used for this
study: OregonR (wild type) and nrg1/FM7c (neuroglian null mutant)
(Leferve and Watkins, 1986, Hall and Bieber, 1997). Embryos were
collected on apple juice agar plates (0-16 H) and were dechorionated
in 50% bleach for whole-mount preparations. The embryos were fixed
in heptane saturated 4% paraformaldehyde in PEM buffer (100 mM
Pipes, 2 mM NaEDTA and 1 mM magnesium sulfate) for 30 minutes,
devitellinized in methanol and washed in phosphate-buffered saline
(PBS) containing 0.1%v/v Triton X-100 (PBT). Then the embryos
were treated with 5% Triton X-100 and 10% horse serum in PBS for
1 hour and incubated with primary antibodies overnight at 4°C with
gentle rocking. Embryos were washed in PBT, incubated in PBT
containing 10% horse serum, and incubated with the secondary
antibodies for 3 hours at room temperature. 
Antibody generation and characterization 
Peptides that corresponded to the sequence surrounding FIGQY in rat
neurofascin with the addition of a cysteine (Cys-Asn-Glu-Asp-Gly-
Ser-Phe-Ile-Gly-Gln-Tyr -Thr-Val-Arg-Lys-Asp) were synthesized in
either their tyrosine phosphorylated or non-phosphorylated forms by
the HHMI peptide synthesis facility at Duke University. Rabbits were
immunized with the tyrosine phosphorylated peptides coupled, via
the extra cysteine, to keyhole limpet hemocyanin (Pierce) as an
immunogenic carrier molecule. An affinity-purified antibody specific
for the phosphorylated FIGQY tyrosine (phospho-FIGQY antibody)
was generated by depleting serum with the non-phosphorylated
FIGQY peptide coupled to NHS-activated-agarose (Amersham
Pharmacia Biotech). The flow-through from this non-phosphorylated
peptide column was then purified using the phosphorylated FIGQY
neurofascin peptide coupled to NHS-activated agarose. Antibody
bound to the phosphorylated peptide was eluted with 4.0 M MgCl2,
and dialyzed against PBS with glycerol, 1.0 mM sodium azide and
1.0 mM NaEDTA at 4°C. 
Immunoblots of brain extracts with this antibody revealed several
bands, one of which was in the cytosolic fraction of embryonic and
neonatal brain extracts, and migrated as a broad band around 350 kDa.
Unlike the other bands recognized, this cytosolic band was not
displaced by the immunizing peptide (data not shown). Two lines of
evidence indicate that this cytosolic band did not contribute to
any of the immunofluorescence seen with the antibody. First,
immunofluorescence with the phospho-FIGQY antibody was
displaced by the FIGQY-phosphorylated neurofascin peptide at all
locations examined. Second, adsorbing the phospho-FIGQY antibody
as described below to eliminate the cytosolic band from immunoblots
had no effect on the pattern of immunofluorescence at any of the
locations examined. 
To eliminate this non-displaceable reactivity in immunoblots,
cytosolic fractions (supernatants following centrifugation for 1 hour
at 100,000 g) of embryonic (E18) and neonatal (P10) rat brain were
coupled to NHS-activated agarose. The phospho-FIGQY antibody
was first adsorbed against the neonatal column followed by the
embryonic column. These adsorption steps eliminated the cytosolic,
non-displaceable band in the immunoblot but had no effect on the
pattern of phospho-FIGQY immunofluorescence in any of the tissues
examined. Therefore, for immunofluorescence, the adsorbed and non-
adsorbed phospho-FIGQY antibodies are used interchangeably. An
example comparing the immunofluorescent pattern of adsorbed
phospho-FIGQY antibody to the non-adsorbed antibody is shown in
Fig. 3. 
The monoclonal antibody recognizing ankyrin G was generated
against a unique peptide in the spectrin-binding domain and is
commercially available from Zymed, Pharmingen and Biomol. 
For initial characterization of the phospho-FIGQY antibody,
peptides corresponding to the sequence surrounding FIGQY in rat
neurofascin (see above), rat L1/NrCAM (Cys-Asn-Glu-Asp-Gly-Ser-
Phe-Ile-Gly-Gln-Tyr -Ser-Gly-Lys-Lys-Glu) and LAD-1 (Cys-Thr-
Glu-Asp-Gly-Ser-Phe-Ile-Gly-Gln-Tyr -Val-Pro-Gln-Lys-Ser) were
synthesized in either their tyrosine phosphorylated or non-
phosphorylated forms. Peptides were coupled to glutaraldehyde-
activated turkey ovalbumin, electrophoresed and immunoblotted with
the phospho-FIGQY antibody as indicated. 
RESULTS
L1 CAMs are phosphorylated at the FIGQY-tyrosine
in mammals and Drosophila
The goal of this study is to determine the cellular localization of
FIGQY-phosphorylated L1-type adhesion molecules in a
physiological context. To accomplish this we developed a
polyclonal antibody capable of specifically recognizing, in
immunoblots and immunofluorescence, the phospho-FIGQY-
tyrosine without crossreacting with other phospho-tyrosine
proteins or with non-phosphorylated L1 CAM family members
(see Materials and Methods). Several lines of evidence support
the conclusion that the phospho-FIGQY polyclonal antibody
specifically recognizes L1-type adhesion molecules
phosphorylated at the FIGQY tyrosine (Fig. 1B-F). Antibody
specificity was initially evaluated with ovalbumin-coupled
peptides corresponding to the phosphorylated or
nonphosphorylated FIGQY-containing sequences of rat
neurofascin (nFIGQY), rat L1/NrCAM (LnFIGQY) or the
relatively divergent LAD-1 of C. elegans(LdFIGQY) (compare
Fig. 1B with 1A for sequence comparison). Loading of equivalent
amounts of protein in each lane was confirmed by Coomassie
Blue staining (data not shown). The phospho-FIGQY polyclonal
antibody did not recognize the non-phosphorylated form of any
of the peptides, but did react strongly with the tyrosine-
phosphorylated nFIGQY peptide and, to a lesser extent,
with the tyrosine-phosphorylated LnFIGQY and LdFIGQY
peptides (Fig. 1B). Antibody phosphorylation specificity in
immunofluorescence was evaluated by pretreating rat embryonic
(E17) forebrain sections, which contain phospho-FIGQY
reactivity (see also Fig. 7), with the tyrosine phosphatase YOP.
Phosphatase treatment eliminated the phospho-FIGQY signal
(Fig. 1C compare – with +) indicating that the phospho-FIGQY
antibody is phospho-tyrosine specific in immunofluorescence.
Shown in Fig. 1C is the region from the marginal zone (MZ) to
the top of the intermediate zone (see Fig. 7 for detailed
description). Antibody specificity for the phosphorylated FIGQY
tyrosine was addressed in B104 rat neuroblastoma cells
transiently expressing either wild-type neurofascin (Y in Fig. 1D)
or a FIGQY to F neurofascin mutant (F in Fig. 1D). Wild-type
neurofascin in untreated cells (Fig. 1D, –) exhibited a low level
of reactivity with the phospho-FIGQY antibody, while mutant
neurofascin was not recognized at all. This residual reactivity
against wild-type neurofascin is consistent with previous
observations in B104 cells using a general phospho-tyrosine
antibody (Garver et al., 1997) that tyrosine phosphorylation is not
totally eliminated by serum starvation. Treatment of transfected
B104 cells with basic fibroblast growth factor (bFGF)
dramatically increased phospho-FIGQY polyclonal antibody
reactivity with wild-type neurofascin but not with mutant
neurofascin, demonstrating specificity of the antibody for the
phosphorylated FIGQY tyrosine. The presence of transfected
neurofascin in all samples was confirmed by a parallel
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immunoblot with a neurofascin-specific polyclonal antibody
(Fig. 1D, top). L1 and neurofascin immunoprecipitated from
either E17 rat brain or P8 cerebellum reacted with the phospho-
FIGQY polyclonal antibody in immunoblots (Fig. 1E).
Moreover, the phospho-FIGQY polyclonal antibody crossreacts
with relatively few polypeptides in embryonic, neonatal and adult
brain (Fig. 1F phospho-FIGQY) while in comparable samples a
general phosphotyrosine antibody reacted with multiple
polypeptides not recognized by the phospho-FIGQY polyclonal
antibody (data not shown). Two of the major phospho-FIGQY-
reactive polypeptides exhibited mobilities of 186 and 155 kDa
(Fig. 1F, phospho-FIGQY), which are similar to those of
neurofascin. Approximately 70% of phospho-FIGQY antibody
reactivity with brain polypeptides was displaced by low levels of
the tyrosine phosphorylated nFIGQY peptide (1 mole peptide per
mole IgG) but no displacement was seen with an equal molar
mount of a tyrosine phosphorylated LVDY peptide of equivalent
length also derived from neurofascin or by a second unrelated
tyrosine phosphorylated peptide corresponding to angiotensin II
(S. M. J. and V. B., unpublished). The tyrosine phosphorylated
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Fig. 1.The phospho-FIGQY polyclonal
antibody is specific for FIGQY-
phosphorylated L1 CAMs. (A) Comparison
of sequences surrounding the FIGQY
tyrosine in neurofascin, L1 and NrCAM,
LAD-1 and neuroglian (long (nrg180) and
short (nrg167) forms). (B) Peptides
corresponding to the sequences shown in A
for either neurofascin (NF), L1 and
NrCAM (L1/Nr), or LAD-1 in their
tyrosine phosphorylated (+) or non-
phosphorylated (−) forms were coupled to
turkey ovalbumin, electrophoresed and
immunoblotted with the phospho-FIGQY
polyclonal antibody. Each lane contains
approximately 200 ng of coupled peptide.
(C) Sections of embryonic (E17) rat
forebrain incubated in the presence (+) or
absence (−) of the tyrosine phosphatase
YOP and immunolabeled with the
phospho-FIGQY polyclonal antibody.
Scale bars: 25 µm. MZ stands for marginal
zone. (D) B104 rat neuroblastoma cells
expressing either wild-type neurofascin (Y), neurofascin with the FIGQY tyrosine mutated to phenylalanine (F) or untransfected controls (con)
were incubated in the presence (+) or absence (−) of bFGF. Extracts were immunoblotted with either a neurofascin-specific polyclonal antibody
(top) or the phospho-FIGQY polyclonal antibody (bottom). (E) Extracts from either E17 rat brain or P6 cerebellum were immunoprecipitated
with a polyclonal antibody against L1, neurofascin (NF) or with control IgG (labeled C). Immunoprecipitates were electrophoresed and
immunoblotted with the phospho-FIGQY polyclonal antibody demonstrating that both L1 and neurofascin are phosphorylated at their FIGQY
tyrosines. (F) Extracts from E17 embryonic brain (E), P10 neonatal brain (N), or adult brain (A) were electrophoresed and immunoblotted with
the phospho-FIGQY polyclonal antibody, a previously characterized neurofascin antibody (NF), and an NrCAM antibody. The low molecular
weight bands observed with the phospho-FIGQY polyclonal antibody in embryonic brain extract were also observed under control conditions
(con) with only 125I-protein A and a control IgG at a similar exposure time. All immunoblots were developed using 125I-protein A except for
(B,E), which were developed using enhanced chemiluminescence. 
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nFIGQY peptide, but not the tyrosine phosphorylated angiotensin
II peptide, also displaced immunofluorescent labeling with the
phospho-FIGQY polyclonal antibody (for example, see Fig. 7).
The ideal control for antibody specificity would be an
organism with null mutations that eliminated expression of all
members of the L1 CAM family. Mice that lack all four L1
CAM family members are not available. However, D osophila
melanogasterexpress a single L1-type adhesion molecule,
neuroglian, and a neuroglian null mutation that is embryonic
lethal has been characterized (Bieber et al., 1989). The
phospho-FIGQY polyclonal antibody recognizes neuroglian
on immunoblots (data not shown). We examined reactivity of
the phospho-FIGQY antibody in Drosophilaembyros between
developmental stages 12 and 15 that were either heterozygous
(Fig. 2A-D) or homozygous (Fig. 2E-H) for the neuroglian
null mutation. Neuroglian nulls can be distinguished from
heterozygous embryos by the absence of neuroglian labeling
(compare Fig. 2F with 2B). In triple labeled embryos, FIGQY-
phosphotyrosine immunoreactivity was present in the nervous
system (Fig. 2C, arrowhead) and epidermal epithelium (Fig.
2C, bracket) of heterozygous embryos but was conspicuously
absent in neuroglian null embryos (Fig. 2G). Fig. 2A,E
demonstrate labeling with an anti-HRP antibody as a control
for antibody penetration into embryos with arrowheads
indicating nervous system labeling. Composite images are
shown in Fig. 2D,H. The lack of immunoreactivity in
neuroglian null fly embryos provides striking confirmation of
the specificity of the phospho-FIGQY polyclonal antibody for
neuroglian. Pre-incubation of the phospho-FIGQY polyclonal
antibody with tyrosine phosphorylated nFIGQY peptide
eliminated the signal, while a comparable amount of the non-
phosphorylated peptide did not (data not shown). The fact that
signal is displaced with phospho- but not dephospho-FIGQY
peptide provides further evidence that the antibody is specific
for FIGQY-phosphorylated neuroglian. 
The developmental expression of FIGQY tyrosine
phosphorylation in the rat brain was examined in E17 embryos
(labeled E in Fig. 1F), P10 neonates (labeled N in Fig. 1F) and
adults (labeled A in Fig. 1F), where the amount of protein in
each lane was matched based on initial brain mass. Embryonic
and neonatal brain contained a phospho-FIGQY-reactive band
of 186 kDa and one at approximately 130 kDa (phospho-
FIGQY, lanes E and N). The low molecular weight bands
surrounding the 30 kDa marker in embryonic brain extract
represent reactivity of protein A itself, as they are present
with control rabbit IgG and 125I-labeled protein A alone at
comparable exposure time (Fig. 1F, Con). The 186 kDa
phospho-FIGQY-reactive band co-migrated with the 186 kDa
isoform of neurofascin (Davis et al., 1993) (Fig. 1F, compare
phospho-FIGQY with NF), while the 130 kDa phospho-
FIGQY-reactive band did not correspond to either neurofascin
or NrCAM. L1 of 130 kDa has been reported (Liljelund et al.,
1994), but does not contain the intracellular domain recognized
by the phospho-FIGQY polyclonal antibody (Liljelund et al.,
1994) and therefore is not responsible for the 130 kDa band
observed in embryonic and neonatal brain. CHL-1 has been
reported to migrate at 125 kDa (Holm et al., 1996). However,
CHL-1 reactivity with the phospho-FIGQY polyclonal
antibody remains to be evaluated directly as the CHL-1
sequence diverges in the FIGQY region (FIGAY for CHL-1). 
Adult brain contained two major phospho-FIGQY-reactive
bands co-migrating with major bands of 186 kDa and 155 kDa
recognized by the neurofascin-specific antibody (Fig. 1F,
compare lane A of phospho-FIGQY and NF) (Davis et al.,
1993). Reactivity of the 186 kDa phospho-FIGQY-reactive
band in adult brain was approximately 1.7 times higher than
that in neonatal brain and three times higher than in embryonic
brain. However, when the level of neurofascin was equated in
brain extract from embyros, neonates and adults, reactivity of
this top band with the phospho-FIGQY polyclonal antibody
was higher in embryo and neonatal brain than adult brain (data
not shown). Pre-incubation of the phospho-FIGQY polyclonal
antibody with a molar excess of the tyrosine phosphorylated
nFIGQY peptide completely displaced these bands (data not
shown). 
FIGQY-phosphorylated L1CAMs are localized at
specialized sites of cell-cell contact at paranodes
and the neuromuscular junction
The finding that FIGQY-phosphorylation of neurofascin
abolishes ankyrin-binding (Garver et al., 1997) suggests that
ankyrin and FIGQY-phosphorylated L1-type adhesion
molecules may be present at distinct sites. Ankyrin G exhibits
a highly restricted localization within the nodal axon segment
Fig. 2.The phospho-FIGQY polyclonal antibody labels developing nervous system and epithelia in neuroglian-expressing but not neuroglian-
null Drosophilaembryos. Drosophilaheterozygotes (A-D) or neuroglian null mutants (E-H), were examined by triple labeling
immunofluorescence with anti-HRP as an antibody penetration control (A,E), anti-neuroglian to distinguish wild type from neuroglian n ll flies
(B,F), and the phospho-FIGQY polyclonal antibody (C,G). Neuroglian nulls exhibited no phospho-FIGQY reactivity. Composite images are
shown in (D,H) with HRP signal indicated in blue. Arrowheads mark the nervous system and brackets mark the epidermal epithelium. Scal
bar: 25 µm. 
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of nodes of Ranvier of myelinated nerves (Kordeli et al., 1995),
while neurofascin is present in both the nodal axon segment
and the paranodal loops of Schwann cells where they contact
the axon (Davis et al., 1996; Tait et al., 2000). Ankyrin G
also is confined within a specialized subdomain of the
neuromuscular junction, where it is colocalized in the
junctional folds with voltage-gated Na+ channels in a location
distinct from the acetylcholine (ACh) receptors, which are in
receptor rich zones adjacent to the presynaptic terminal
(Flucher and Daniels, 1989; Wood and Slater, 1998; Kordeli et
al., 1998). Although L1 CAMs have not yet been identified at
mammalian neuromuscular junctions, neuroglian is present at
the developing neuromuscular junction of fly embryos (Fig. 5).
We therefore examined nodes of Ranvier of rat sciatic nerve
and the neuromuscular junction of rat and Drosophila for the
presence of FIGQY-phosphorylated L1CAMs. 
Nodes of Ranvier exhibit a prominent paranodal distribution
of a FIGQY-phosphorylated L1 CAM and reduced or absent
FIGQY-phosphotyrosine labeling at the nodal axon segment,
which is marked by staining with the antibody against ankyrin-
G (Fig. 3). Composite images (3C, F and I) reveal a striking
segregation of ankyrin G (green) from phospho-FIGQY label
(red). By contrast, total neurofascin, as revealed by a
neurofascin-specific polyclonal antibody (Davis et al., 1993),
is found in both the node of Ranvier and the paranodes
(Fig. 3J-L). The majority of total neurofascin is found at the
node making the paranodal phospho-FIGQY signal more
remarkable. The phospho-FIGQY polyclonal antibody also
labeled longitudinally oriented structures in the sciatic nerve
that likely correspond to unmyelinated axons, as described
previously (Davis et al., 1996) (data not shown). A similar
paranodal distribution of phospho-FIGQY was observed with
the cytosol-adsorbed phospho-FIGQY polyclonal antibody
(Fig. 3G-I) (see Materials and Methods for description of
cytosol-adsorption). Paranodal phospho-FIGQY labeling was
displaced by pre-incubating the antibody with the tyrosine
phosphorylated nFIGQY peptide (data not shown, see Fig. 7
for an example of peptide displacement). 
We also observed FIGQY-phosphotyrosine label
postsynaptically at the adult rat neuromuscular junction. Fig. 4
shows thin sections of adult neuromuscular junction labeled
with α-bungarotoxin, to visualize ACh receptors (Fig. 4A,D),
and either the ankyrin-G monoclonal antibody (Fig. 4B) or the
phospho-FIGQY polyclonal antibody (Fig. 4E). Phospho-
FIGQY label co-localizes with the ACh receptors at the crests
of junctional folds (Fig. 4F), while ankyrin G is localized
exclusively to the deep regions of junctional folds and does not
overlap with ACh receptor expression (Fig. 4C). Several
regions of punctate phospho-FIGQY labeling are visible. No
phospho-FIGQY labeling is seen in the junctional folds.
Phospho-FIGQY labeling was eliminated by pre-incubating
the antibody with the tyrosine phosphorylated nFIGQY peptide
(data not shown). Antibodies against neurofascin, NrCAM and
L1 failed to label the neuromuscular junction postsynaptically
in a pattern similar to the phospho-FIGQY polyclonal antibody
(data not shown). The L1 polyclonal antibody labeled
presynaptic structures at the neuromuscular junction (data not
shown). These results suggest that the L1 CAM present at the
neuromuscular junction either is distinct from neurofascin, L1
and NrCAM, or that it represents a splice form not recognized
by our antibodies. 
FIGQY-phosphorylated neuroglian localizes to the
developing neuromuscular junction of Drosophilaembryos at
stage 16/17 (Fig. 5A-C, white arrowheads), as indicated by
overlap with the junctional marker fasciclin II (Fas II) (Schuster
et al., 1996) (Fig. 5C, white arrowhead). We were unable to
distinguish presynaptic from postsynaptic sites in Drosophila
embryos. The presence of neuroglian at the neuromuscular
junction was confirmed by double labeling with the anti-
neuroglian antibody 1B7 (Bieber et al., 1989) (Fig. 5D, white
arrowhead) and the phospho-FIGQY polyclonal antibody
(white arrowheads in Fig. 5E,5F for overlap). At this stage, the
presynaptic terminal has contacted the muscle but has not yet
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Fig. 3. FIGQY phosphorylation is concentrated in paranodal regions
of adult sciatic nerve. Sections of adult rat sciatic nerve were labeled
with either the phospho-FIGQY polyclonal antibody (A,D,G) or a
neurofascin-specific polyclonal antibody (J). Nodes of Ranvier were
visualized with the monoclonal antibody against ankyrin G
(B,E,H,K). Composite images (C,F,I) demonstrate the minimal
overlap between nodal ankyrin G (green) and paranodal phospho-
FIGQY (red). The neurofascin-specific polyclonal antibody
recognizes both nodes and paranodes (J-L). The phospho-FIGQY
polyclonal antibody in G was cytosol cleared, demonstrating no
difference in the pattern of immunofluorescence with cytosol
clearing (see Materials and Methods for details). White arrowheads
indicate the location of nodes of Ranvier. Scale bars: 5 µm in A-I;
2.5 µm in J-L. 
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formed the varicosities that develop into the characteristic
synaptic boutons of the larval neuromuscular junction (Broadie,
1999). FIGQY phosphorylation was no longer evident in the
larval neuromuscular junction (data not shown), indicating the
developmental nature of this phosphorylation event in
Drosophilaand suggesting that the specific function of FIGQY
phosphorylation at the neuromuscular junction is different in
Drosophilaand vertebrates. 
In addition to this junctional staining, some phospho-FIGQY
labeling did not overlap with Fas II (yellow arrowheads in 5).
These structures correspond to sites of muscle-tendon cell
attachment, which are epidermal muscle attachment sites
Fig. 4. FIGQY-phosphorylation occurs at the vertebrate neuromuscular junction. ACh receptors at the rat neuromuscular junction as labeled by
bungarotoxin (A,D) are confined to the crests of junctional folds while ankyrin G (B) is confined to the deep regions of these folds in muscle
cell plasma membrane. The two distributions do not overlap (C, arrows indicate identical position in all three images). FIGQY-phosphorylation
(E) is strictly confined to the crests of junctional folds with ACh receptors (D) but has a more punctate distribution than ACh receptors.
Composite images are shown in C,F. Scale bar: 2 µm. N, location of nerve terminals; M, muscle cell.
Fig. 5.FIGQY phosphorylated neuroglian is present at the developing neuromuscular junction and at sites of muscle-tendon attachment in
Drosophilaembryos. (A) The developing neuromuscular junction of Dr sophilaembryos is shown as marked by Fas II labeling (white
arrowhead). FIGQY-phosphorylated neuroglian is present at the neuromuscular junction (B, C for composite). (D-F) Embryos were labeled
with an anti neuroglian antibody (D) and the phospho-FIGQY polyclonal antibody (E). A composite image is shown in F, with the developing
neuromuscular junction marked by a white arrowhead. The phospho-FIGQY polyclonal antibody also labels muscle-tendon attachment si es
(B-I, yellow arrowheads) as indicated by overlap with PSα2 (G) (yellow arrowheads). Composite image shown in (L). Neuroglian is also
present at these sites (D-F, yellow arrowheads) although it is not dramatically enriched. Scale bars: 10 µm. A, axon of presynaptic nerve cell;
M, muscle cell.
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(Tepass and Hartenstein, 1994), as indicated by their overlap
with the position-specific integrin PSα2 (Fig. 5G-I, yellow
arrowheads) (Martin-Bermudo and Brown, 1996). While
neuroglian is present at these attachment sites (Fig. 5D-F,
yellow arrowheads), it is not much enriched suggesting that the
neuroglian that is present is highly FIGQY-phosphorylated.
The phospho-FIGQY signal was displaced by pre-incubation
of the antibody with phosphorylated nFIGQY peptide (data not
shown). 
FIGQY-phosphorylated L1-type adhesion molecules
are concentrated in adherens junctions of epithelial
cells 
Neuroglian expression occurs in multiple epithelial tissues of
Drosophila (Bieber et al., 1989; Hortsch et al., 1990). We
therefore examined epithelial tissues of wild-
type embryos between stages 12 and 15 for
FIGQY-phosphorylated neuroglian (Fig. 6).
Neuroglian (phosphorylated plus dephorylated
forms) is localized along the basolateral
domains of epithelial cells of the hindgut (Fig.
6B) while FIGQY-phosphotyrosine label is
highly enriched in an apicolateral domain (Fig.
6A) identified as adherens junctions by co-
localization with the adherens junction marker
armadillo/β-catenin (Fig. 6E) (Cox et al., 1996).
The merged image in Fig. 6F demonstrates
the striking overlap between FIGQY-
phosphorylated neuroglian and armadillo (areas
of overlap in yellow) at adherens junctions.
Some FIGQY-phosphorylated neuroglian is also
present at the interface between gut epithelium
basolateral membranes and visceral muscle ,
and probably corresponds to hemi-adherens
junctions based on location (Tepass and
Hartenstein, 1994) (Fig. 6A). 
FIGQY-phosphotyrosine label also is
concentrated in adherens junctions of
embryonic rat lung epithelium (Fig. 6G). A
higher magnification image of the boxed region
in Fig. 6G is shown in Fig. 6H. Antibodies
against L1 and NrCAM did not label lung
epithelium although some signal was observed
with a neurofascin-specific antibody (data not
shown). Adult lung epithelium did not contain
FIGQY-phosphotyrosine label, indicating the
developmental nature of this phosphorylation
event (data not shown). FIGQY-
phosphotyrosine label also was concentrated in
apical regions of the E15 rat midgut, although it
was not possible to resolve adherens junctions
in these sections (Fig. 6I). A similar distribution
of NrCAM is demonstrated in Fig. 6J,
suggesting that NrCAM may be phosphorylated
at the FIGQY tyrosine in this tissue. L1 did not
exhibit a similar distribution (data not shown).
The phospho-FIGQY polyclonal antibody
signal in the gut and lung was completely
displaced by pre-incubation with the tyrosine-
phosphorylated nFIGQY peptide (data not
shown). 
FIGQY-phosphorylated L1 CAMs are present in
regions of the central nervous system enriched in
motile cells 
Extensive neuronal migration and axon extension occur in the
late embryonic rat forebrain (Hatten, 1999; Bar et al., 2000).
Neuroblasts are generated in the ventricular zone and then
migrate outward and settle in an inside-out manner to produce
the layered structure of the mature cortex. The phospho-FIGQY
polyclonal antibody labels cells lining the lateral ventricle (LV),
in the intermediate zone (IZ) and in the marginal zone (MZ) in
the embryonic day 17 rat forebrain (Fig. 7A). Regions were
defined as in Bar et al. (Bar et al., 2000). Distributions of both
neurofascin (Fig. 7C) and L1 (Fig. 7D) are similar to that of
FIGQY tyrosine phosphorylation (Fig. 7B) in the anterior
intermediate zone of the developing cortex of an E18 rat embryo.
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Fig. 6.FIGQY-phosphorylated L1 CAMs are localized to adherens junctions in
vertebrate and Drosophilaepithelial tissues. Drosophilaembryos at stage 12-15 were
labeled with a neuroglian antibody (B), demonstrating the presence of neuroglian in
the basolateral domain of the hindgut. Labeling the same embryo with the phospho-
FIGQY polyclonal antibody (A) revealed FIGQY-phosphorylated neuroglian
concentrated in apicolateral regions. Composite image is shown in C. Embryos were
also labeled with the adherens junction marker armadillo (E) and the phospho-FIGQY
polyclonal antibody (D). A composite image is shown in F, with areas of overlap in
yellow. (G) A section of E15 rat lung was labeled with the phospho-FIGQY
polyclonal antibody demonstrating labeling at adherens junctions. A higher
magnification image of the boxed area in G is shown in H. (I) The phospho-FIGQY
polyclonal antibody signal is concentrated apically in the developing midgut of the
E15 rat. Adherens junctions could not be resolved in these sections. NrCAM shows a
similar distribution (J). Scale bars: 10 µm in A-C,G,I,J; 5 µm in D-F. 
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These data in conjunction with the immunoprecipitation data
(Fig. 1) suggest that both neurofascin and L1 in the embryonic
brain intermediate zone are phosphorylated at the FIGQY
tyrosine. The complexity of the tissue and the overlapping
expression of multiple ankyrins made it difficult to draw
firm conclusions about the relative distributions of FIGQY
phosphorylation and ankyrin (data not shown). 
As a control for antibody specificity, serial sections of
embryonic rat brain (E15) were labeled with phospho-FIGQY
polyclonal antibody that had been pre-incubated with either
a fivefold molar excess of tyrosine phosphorylated nFIGQY
peptide (Fig. 7F), a fivefold molar excess of tyrosine
phosphorylated angiotensin II peptide (Fig. 7G), or in the
absence of peptide (Fig. 7E). The nFIGQY peptide eliminated
the phospho-FIGQY signal, while the tyrosine phosphorylated
angiotensin peptide did not. These results provide further
evidence for the specificity of the phospho-FIGQY polyclonal
antibody for the tyrosine-phosphorylated FIGQY sequence of
L1 CAMs as examined by immunofluorescence. 
Granule cells in the neonatal cerebellum migrate from their
site of proliferation in the external germinal layer (EGL), to
their final destination, the internal granule cell layer (IGL).
During migration, granule cells extend axons in the molecular
layer (ML) (Hatten, 1999). Sections of neonatal cerebellum
labeled with the phospho-FIGQY polyclonal antibody revealed
the presence of FIGQY-phosphorylated L1 CAMs in the
migratory and pre-migratory granule cells of the external
germinal layer, and in elongating granule cell axons of the
molecular layer (Fig. 7H). FIGQY phosphorylation was less
intense in the internal granule cell layer containing post-
migratory granule cells and granule cells nearing the end of the
migratory pathway. This signal was completely eliminated
by pre-incubation of the antibody with the tyrosine
phosphorylated nFIGQY peptide (data not shown). The
phospho-FIGQY polyclonal antibody label co-localized with
the expression of neuron-specific β-tubulin but not with the
glial marker GFAP (S.M.J. and V.B., unpublished) suggesting
that the cerebellar FIGQY-phosphorylated L1 CAM is
Fig. 7.FIGQY tyrosine phosphorylation
occurs in regions of neuroblast generation
and migration and regions of axon
extension. (A) A low magnification image of
an E17 rat brain labeled with the phospho-
FIGQY polyclonal antibody. The anterior
region of developing cortex in E18 brain
sections was labeled with the phospho-
FIGQY polyclonal antibody (B), a
neurofascin polyclonal antibody (C) or an
L1 polyclonal antibody (D) showing overlap
between expression of these L1 CAMs and
phospho-FIGQY. A similar pattern of
phospho-FIGQY labeling in E15 embyros
(E) was displaced when the phospho-
FIGQY polyclonal antibody was pre-
incubated in the presence of a fivefold molar
excess of tyrosine phosphorylated nfFIGQY
peptide (F) but not in the presence of a
fivefold molar excess of tyrosine
phosphorylated AngII peptide (G). Sections
of P8 cerebellum were labeled with the
phospho-FIGQY polyclonal antibody (H), a
polyclonal antibody against neurofascin
FNIII domains (I) or a polyclonal antibody
against L1 (J) showing an overlapping
distribution of phospho-FIGQY and L1
CAMs. (K-M) The presence of FIGQY
phosphorylation in adult brain in neuroblasts
migrating in the rostral migratory stream
from the lateral ventricle to the olfactory
bulb is shown. The phospho-FIGQY
polyclonal antibody label partially overlaps
with the early neuronal marker β III tubulin
in the subventricular zone (L) and (M) for
overlap. CP, cortical plate; EGL, external
germinal layer; IGL, internal granule cell
layer; IZ, intermediate zone; LV, lateral
ventricle; ML, molecular layer;
MZ, marginal zone; VZ, ventricular zone.
Scale bars: 100 µm in A; 25 µm in B-M. 
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neuronal and is not restricted to sites of neuron-glia contact.
The distribution of FIGQY-phosphotyrosine label overlaps
with the expression patterns of both neurofascin and L1 (Fig.
7I,J, respectively) in the molecular layer and the internal
granule cell layer, supporting the immunoprecipitation data
(see above) demonstrating that both neurofascin and L1 are
phosphorylated at their FIGQY-tyrosine residues in neonatal
cerebellum. Expression of both L1 CAMs is greatly reduced
in the external germinal layer. Phosphorylation of the FIGQY
tyrosine was not detected in the adult cerebellum (data not
shown) indicating the transient and developmental nature of
this phosphorylation event. 
In adult rats, cells from the subventricular zone of the lateral
ventricle migrate to the olfactory bulb along the rostral
migratory stream (Lois and Alvarez-Buylla, 1994; Lois et al.,
1996). The phospho-FIGQY polyclonal antibody labels cells
in this region of continued neurogenesis and neuronal
migration (Fig. 7K). The rostral migratory stream was
identified based on the location and morphology of cells
labeled with the phospho-FIGQY polyclonal antibody, and the
overlap between the phospho-FIGQY signal with neuron-
specific β-tubulin in the subventricular zone (Fig. 7L,M)
(Rousselot et al., 1995), Moreover, the phospho-FIGQY signal
overlaps with that of doublecortin (data not shown), which is
a marker of migrating neurons that labels cells in the rostral
migratory stream (Gleeson et al., 1999). The phospho-
FIGQY signal was completely displaced by the tyrosine
phosphorylated nFIGQY peptide (data not shown). 
DISCUSSION
This study provides the first physiological insight, in both
Drosophilaand vertebrates, into the cellular localization of a
functionally important phosphorylation event in a major class
of adhesion molecules. L1-type cell adhesion molecules
phosphorylated at the FIGQY tyrosine are localized to
specialized sites of cell-cell contact, including paranodes of
adult sciatic nerve, the neuromuscular junction of adult rats and
Drosophilaembyros, muscle-tendon junctions of Drosophila,
and adherens junctions of developing epithelial cells of rat and
Drosophila. In C. elegans, FIGQY-phosphorylated LAD-1 also
is localized to adherens junctions of epithelial tissues and sites
of body wall-muscle attachment (Chen et al., 2001). In
addition, FIGQY-phosphorylated neurofascin and L1 are
abundantly expressed in regions of neuronal migration and
axon extension in the vertebrate central nervous system,
including the embryonic cortex, the neonatal cerebellum and
the adult rostral migratory stream. These findings establish that
FIGQY-tyrosine phosphorylation of L1-type family members
first characterized in cultured neuroblastoma cells (Garver et
al., 1997), also occurs under physiological conditions and
is evolutionarily conserved between flies, nematodes and
mammals. 
In cultured cells, phosphorylation of the FIGQY tyrosine
of neurofascin decreases neurofascin-ankyrin interactions
(Garver et al., 1997; Tuvia et al., 1997). If FIGQY-
phosphorylation performs a similar role under physiological
conditions, then discrete, well-defined regions of ankyrin
expression might remain distinct from regions containing
FIGQY-phosphorylated L1-type adhesion molecules.
Moreover, ankyrin may colocalize with L1-type adhesion
molecules not phosphorylated at the FIGQY tyrosine. This is
precisely what we observe at the neuromuscular junction and
sciatic nerve nodes of Ranvier. At the neuromuscular junction,
ankyrin is confined to the depths of junctional folds and
FIGQY phosphorylation to the crests of these folds, while at
nodes of Ranvier clustered ankyrin G colocalizes with
neurofascin and NrCAM that are not phosphorylated at the
FIGQY tyrosine. Together, these results suggest that one
physiological function of FIGQY phosphorylation is to
regulate the interaction between L1 CAMs and ankyrin
establishing ankyrin-containing and/or ankyrin-free
microdomains. Through this mechanism FIGQY
phosphorylation may play a role in morphogenesis of the node
of Ranvier. Premyelinated axons contain uniformly distributed
FIGQY-phosphorylated L1 CAMs (S.M.J. and V.B.,
unpublished), possibly localized in vesicles, which are
subsequently targeted to specific domains in the plasma
membrane. Localized dephosphorylation of neurofascin or
NrCAM by a receptor tyrosine phosphatase could initiate
recruitment of ankyrin G, which could, in turn, recruit voltage-
gated Na+ channels, which are dependent on ankyrin for
restriction to axon initial segments (Zhou et al., 1998). Voltage-
gated Na+ channels associate with RPTP-β protein tyrosine
phosphatase (Ratcliffe et al., 2000), and could participate in
their own assembly and/or maintenance at the nodal axon
segment. In support of such a model, examination of the
developing sciatic nerve has revealed early clusters of
neurofascin lacking ankyrin-G, followed by co-clustering of
neurofascin and ankyrin G, and finally by recruitment of
voltage-gated Na+ channels (Lambert et al., 1997). 
In cultured cells, FIGQY phosphorylation of neurofascin
also decreases neurofascin-mediated intercellular adhesion
(Tuvia et al., 1997). A similar role for FIGQY phosphorylation
might be important physiologically in cells undergoing
migration or other forms of motility such as neurite extension.
The combination of decreased intercellular adhesion and the
destabilization of adhesion molecule-cytoskeletal linkages
could be necessary for cell motility. The prominence of FIGQY
phosphorylation in regions of neuroblast migration and axon
extension is consistent with this hypothesis. 
Spatial segregation between FIGQY phosphorylation and
ankyrin expression (Chen et al., 2001) and the remarkably
focussed distribution of FIGQY phosphorylation compared to
total L1-type adhesion molecule distribution, particularly at
adherens junctions, also suggests that FIGQY-phosphorylated
L1-type adhesion molecules participate in an ankyrin-
independent signaling/structural pathway. Key components of
 phospho-FIGQY L1 CAM pathway including ligands,
protein kinase(s) and protein phosphatase(s) remain to be
lucidated. However, an adaptor protein that binds specifically
to FIGQY-phosphorylated neurofascin has recently been
i entified as doublecortin (K.K. and V.B., unpublished).
Doublecortin is involved in neuronal migration and is mutated
in human neuronal migration disorders (des Portes et al., 1998;
Gleeson et al., 1998; Sossey-Alaoui et al., 1998; Francis et al.,
1999; Gleeson et al., 1999) suggesting the potential clinical
importance of FIGQY tyrosine phosphorylation. Whether
other phospho-FIGQY adaptors exist in non-neuronal tissues
(e.g. adherens junctions) remains to be determined. The
conservation of FIGQY phosphorylation between vertebrates,
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Drosophila and C. elegansat adherens junctions suggests a
fundamentally important role for FIGQY phosphorylation in
adhesion molecule function at these sites. In vertebrates at
least, this role is transient during development consistent with
an active signaling function rather than a more passive
structural role. 
Other specialized sites of cell-cell contact containing
FIGQY-phosphorylation include paranodes of adult sciatic
nerve and the neuromuscular junction. In adult vertebrate
sciatic nerves, the paranodal phospho-FIGQY-containing
protein is presumably neurofascin (Davis et al., 1996; Tait et
al., 2000). Although we could not distinguish axonal from glial
labeling at the light level, paranodal phospho-FIGQY probably
represents the 155 kDa neurofascin isoform recently identified
as a glial component of the septate-like junction anchoring
axons to myelinating glia (Tait et al., 2000; Trapp and Kidd,
2000). In Drosophila, although neuroglian expression has been
demonstrated in muscle cells (Hortsch et al., 1990), the present
findings provide the first evidence for the presence of an L1-
type family member at the neuromuscular junction. FIGQY-
phosphorylation of neuroglian was seen in the embryonic
but not the larval neuromuscular junction, while the adult
vertebrate neuromuscular junction contained FIGQY
phosphorylation. Thus, the specific function of junctional
FIGQY phosphorylation is different in flies and vertebrates.
The vertebrate L1 CAM at the neuromuscular junction may
represent a splice variant not recognized by our antibodies or,
by elimination, could be CHL1, the only vertebrate L1 CAM
not examined in the present study. CHL1 diverges in the
FIGQY (FIGAY in the case of CHL1) region and reactivity
with the phospho-FIGQY polyclonal antibody remains to be
evaluated. Similar reasoning can be applied to regions of the
nervous system containing FIGQY phosphorylation that did
not overlap with examined L1 CAMs. 
The protein kinase(s) that phosphorylates the FIGQY
tyrosine is unknown. FIGQY phosphorylation of LAD-1 in
C. elegans epithelial tissues depends on the fibroblast growth
factor receptor (FGFR) but not the epidermal growth factor
receptor (EGFR) and ROR kinase (Chen et al., 2001). FIGQY
phosphorylation in FGFR mutants was rescued by gain of
function Ras indicating that a protein kinase downstream of the
FGFR directly phosphorylates LAD-1 (Chen et al., 2001). The
tyrosine kinase Src did not phosphorylate a bacterially-
expressed neurofascin cytoplasmic domain construct (S.M.J.
and V.B., unpublished), suggesting that Src and possibly
related protein tyrosine kinases do not phosphorylate the
FIGQY tyrosine directly. The C. elegansROR receptor
tyrosine kinase is homologous to mammalian muscle-specific
kinase (MuSK) found at the neuromuscular junction
(Valenzuela et al., 1995), arguing against the hypothesis that
MuSK phosphorylates the L1 CAM localized to postsynaptic
folds of the neuromuscular junction. 
The presence of FIGQY-phosphotyrosine label in diverse but
highly specific sites and in multiple L1 family members
suggests that the signaling pathway that regulates this
phosphorylation event is of general importance to the normal
functioning of the L1-type adhesion molecule family.
Elucidation of other components of the FIGQY-signaling
pathway may be accessible using genetic approaches in
Drosophila and C. elegans. The L1-type adhesion molecules
share three other conserved tyrosine residues in their
cytoplasmic domains that may function as targets for protein
tyrosine kinase(s). Concerted regulation of the phosphorylation
of these tyrosines could allow for a complex role in cell
signaling. It also is worth noting that the present work provides
a conceptually straightforward approach using antibodies to
localize proteins phosphorylated at specific sites that could be
used to investigate the physiological occurrence of specific
signaling events in other cell adhesion molecules such as
integrins and cadherins.
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